Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Liver cancer: Benefitting from increasing choices of treatment option

BCLC Stage C HCC: Do we have the best sequence of treatment? 

Date

16 Sep 2021

Session

Liver cancer: Benefitting from increasing choices of treatment option

Topics

Tumour Site

Hepatobiliary Cancers

Presenters

Lam Chan

Authors

L.S. Chan

Author affiliations

  • Clinical Oncology Department, The Chinese University of Hong Kong - Sino Building, Sha Tin/HK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Huichuan Sun

Session: Liver cancer: Benefitting from increasing choices of treatment option

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.